选择性肝动脉栓塞治疗巨大肝血管瘤46例  

Transarterial embolization for treatment of giant hepatic hemangiomas:An analysis of 46 cases

作　　者：范沙丽[1] 佟小强[1] 王健[1] 宋莉[1] 

机构地区：[1]北京大学第一医院介入血管外科,北京市100034

出　　处：《世界华人消化杂志》2013年第20期1925-1930,共6页World Chinese Journal of Digestology

摘　　要：目的:评价选择性肝动脉栓塞术(transcatheter arterial embolization,TAE)治疗巨大肝血管瘤的长期临床疗效.方法:回顾性分析了2003-02/2010-06在我院进行选择性TAE治疗的46例肝血管瘤患者.对栓塞前后病灶大小及并发症出现情况进行分析.结果:共治疗46个病灶,瘤体最大径平均9.2cm,栓塞治疗成功率为100%.随访3-106mo,瘤体从9.2cm缩小到4.0cm(P<0.05).随访中,8例病灶消失,18例术前有临床症状者,12例症状消失,6例症状明显缓解.术后27例出现栓塞后综合征,无严重并发症.结论:选择性肝动脉栓塞治疗肝血管瘤技术上安全可行,长期疗效确切可靠.AIM：To evaluate the long-term outcome of transarterial embolization（TAE） in patients with giant hepatic hemangiomas.METHODS：This retrospective study included 46 patients with giant hepatic hemangiomas who were treated by TAE at our hospital from February 2003 to October 2010.Changes in tumor size between pre-and post-treatment were evaluated,and complications such as changes in liver function were analyzed as well.RESULTS：The mean diameter of hemangiomas before TAE was 9.2 cm.All the patients were followed by ultrasound（US）/computed tomography（CT）/magnetic resonance imaging（MRI） for 3 to 106 mo.Follow-up radiological examinations revealed that the mean diameter of hemangiomas was 4.0 cm after treatment,and the reduction of tumor size was statistically significant（P 0.05）.Symptoms related to hemangiomas were relieved in all the patients.Minor complications were found in 27 cases（58.7%） after embolization,and no severe complication occurred.CONCLUSION：TAE is safe and reliable in the treatment of giant hepatic hemangiomas in terms of long-term efficacy.

关 键 词：肝血管瘤 动脉栓塞 栓塞综合征 

分 类 号：R735.7[医药卫生—肿瘤]